StockWatch: Insmed Shares Leap 150%, as Analysts See Next Blockbuster
Insmed (INSM) wowed investors this past week as its shares more than doubled, leaping 150% after the Bridgewater, NJ-based drug developer announced plans to file for its second approval with the FDA later this year based on positive Phase III data that a …